HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qi Cao Selected Research

Matrix Metalloproteinases (MMPs)

5/2017Matrix metalloproteinase 9-dependent Notch signaling contributes to kidney fibrosis through peritubular endothelial-mesenchymal transition.
3/2010Macrophage matrix metalloproteinase-9 mediates epithelial-mesenchymal transition in vitro in murine renal tubular cells.
1/2007Leptin represses matrix metalloproteinase-1 gene expression in LX2 human hepatic stellate cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qi Cao Research Topics

Disease

78Neoplasms (Cancer)
05/2024 - 07/2006
41Prostatic Neoplasms (Prostate Cancer)
05/2024 - 09/2003
27Inflammation (Inflammations)
01/2024 - 03/2004
21Fibrosis (Cirrhosis)
03/2023 - 10/2003
17Neoplasm Metastasis (Metastasis)
01/2022 - 11/2006
16Infections
01/2023 - 02/2014
14Renal Cell Carcinoma (Grawitz Tumor)
11/2020 - 01/2017
12Bites and Stings (Sting)
12/2023 - 01/2021
9Carcinogenesis
01/2024 - 11/2005
8Liver Cirrhosis (Hepatic Cirrhosis)
08/2023 - 04/2002
8Breast Neoplasms (Breast Cancer)
12/2022 - 09/2003
6Alcoholic Fatty Liver
04/2024 - 03/2004
6Atherosclerosis
08/2022 - 01/2017
6Proteinuria
01/2022 - 09/2008
6Kidney Diseases (Kidney Disease)
01/2020 - 07/2013
5Cardiovascular Diseases (Cardiovascular Disease)
08/2022 - 01/2018
5Insulin Resistance
01/2019 - 03/2004
4Obesity
10/2023 - 01/2017
4Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
09/2023 - 10/2016
4Wounds and Injuries (Trauma)
11/2022 - 11/2006
4Lung Neoplasms (Lung Cancer)
01/2022 - 07/2009
4Necrosis
01/2022 - 05/2002
4Hypoxia (Hypoxemia)
01/2022 - 04/2009
4Glomerulonephritis
01/2022 - 12/2007
4Pneumonia (Pneumonitis)
01/2021 - 11/2017
4Reperfusion Injury
01/2021 - 01/2018
4Fatty Liver
01/2020 - 03/2008
4Kidney Neoplasms (Kidney Cancer)
01/2019 - 01/2017
4Alcoholic Liver Diseases (Alcoholic Liver Disease)
01/2012 - 12/2002
4Ovarian Neoplasms (Ovarian Cancer)
04/2009 - 07/2006
3Carcinoma (Carcinomatosis)
02/2024 - 04/2010
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
06/2023 - 04/2015
3Acute Kidney Injury (Acute Renal Failure)
04/2022 - 12/2006
3Chronic Renal Insufficiency
01/2020 - 05/2012
3Glioma (Gliomas)
11/2019 - 12/2015
3Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
11/2019 - 12/2007
3Nephrosis
10/2013 - 06/2008

Drug/Important Bio-Agent (IBA)

31Proteins (Proteins, Gene)FDA Link
02/2024 - 09/2003
24CytokinesIBA
12/2023 - 05/2002
18Biomarkers (Surrogate Marker)IBA
06/2023 - 11/2008
16Messenger RNA (mRNA)IBA
01/2021 - 03/2004
12DNA (Deoxyribonucleic Acid)IBA
10/2023 - 02/2013
9AndrogensIBA
11/2023 - 08/2007
9Antiviral Agents (Antivirals)IBA
10/2023 - 01/2021
9RNA (Ribonucleic Acid)IBA
06/2023 - 07/2011
8LipidsIBA
02/2024 - 01/2018
8Long Noncoding RNAIBA
07/2021 - 07/2011
7Phosphotransferases (Kinase)IBA
10/2023 - 07/2006
7Glucose (Dextrose)FDA LinkGeneric
04/2022 - 01/2017
7Androgen Receptors (Androgen Receptor)IBA
01/2021 - 10/2009
6InterferonsIBA
04/2024 - 01/2022
6Doxorubicin (Adriamycin)FDA LinkGeneric
01/2023 - 06/2008
6Ethanol (Ethyl Alcohol)IBA
01/2022 - 12/2002
6CateninsIBA
01/2021 - 01/2016
6CollagenIBA
01/2020 - 01/2006
6MicroRNAs (MicroRNA)IBA
04/2019 - 06/2011
6Insulin (Novolin)FDA Link
01/2019 - 03/2004
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2018 - 12/2002
5ChromatinIBA
02/2024 - 01/2013
5Hormones (Hormone)IBA
09/2023 - 11/2008
5Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2023 - 03/2010
5VaccinesIBA
09/2022 - 12/2008
5Therapeutic UsesIBA
01/2021 - 09/2010
5Transcription Factors (Transcription Factor)IBA
01/2020 - 07/2010
5AntigensIBA
01/2019 - 02/2013
4Indicators and Reagents (Reagents)IBA
02/2024 - 10/2018
4Peptides (Polypeptides)IBA
11/2023 - 05/2020
4Interleukin-6 (Interleukin 6)IBA
06/2023 - 04/2015
4Small Interfering RNA (siRNA)IBA
01/2023 - 04/2009
4Estrogen ReceptorsIBA
12/2022 - 06/2009
4EnzymesIBA
12/2022 - 03/2008
4AntioxidantsIBA
11/2022 - 01/2006
4Estrogens (Estrogen)FDA Link
01/2022 - 11/2006
4Transforming Growth Factors (Transforming Growth Factor)IBA
01/2021 - 01/2014
4Polycomb-Group ProteinsIBA
10/2020 - 09/2003
4Sunitinib (Sutent)FDA Link
09/2020 - 01/2017
4LipopolysaccharidesIBA
01/2020 - 05/2012
3InflammasomesIBA
12/2023 - 01/2018
3MethyltransferasesIBA
11/2023 - 11/2019
3cyclic guanosine monophosphate-adenosine monophosphateIBA
10/2023 - 01/2022
3enzalutamideIBA
10/2023 - 01/2018
3Interleukin-33IBA
11/2022 - 01/2018
3Reactive Oxygen Species (Oxygen Radicals)IBA
11/2022 - 01/2019
3Amino AcidsFDA Link
01/2022 - 02/2009
3fucoidanIBA
09/2021 - 03/2019
3ICG 001IBA
01/2021 - 01/2018
3ChemokinesIBA
11/2019 - 12/2008
3Complement System Proteins (Complement)IBA
11/2018 - 06/2012
3NF-kappa B (NF-kB)IBA
01/2018 - 07/2006
3Matrix Metalloproteinases (MMPs)IBA
05/2017 - 01/2007
3Toll-Like Receptors (Toll-Like Receptor)IBA
01/2017 - 07/2009
3CreatinineIBA
01/2015 - 06/2011
3Proto-Oncogene Proteins c-etsIBA
10/2012 - 01/2008
3Progestins (Progestagens)IBA
04/2009 - 11/2006
3Cytochrome P-450 CYP2E1 (CYP2E1)IBA
10/2007 - 07/2005

Therapy/Procedure

29Therapeutics
05/2024 - 12/2007
11Castration
01/2024 - 06/2017
7Immunotherapy
01/2024 - 01/2018
4Chinese Traditional Medicine (Traditional Chinese Medicine)
12/2022 - 01/2017
3Drug Therapy (Chemotherapy)
10/2021 - 06/2017